Skip to main content

Table 2 Measures of depression severity (PHQ-9), cognitive function (PDQ-D), cognitive performance (DSST), and emotional well-being (WHO-5)

From: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study

Measures

Baseline (Day 1)

Week 6

Week 12

PHQ-9

 n

110

109

111

 Mean (SD)

15.7 (4.8)

8.9 (5.9)

7.1 (5.6)

Change from baseline

 n

103

106

 Mean (SD)

−6.5 (6.2)

−8.4 (6.2)

P value

<0.001

<0.001

PDQ-D

 n

110

106

108

 Mean (SD)

40.5 (14.9)

25.7 (14.9)

22.2 (15.9)

Change from baseline

 n

104

106

 Mean (SD)

−14.8 (13.7)

−18.0 (16.9)

P value

<0.001

<0.001

DSST

 n

113

107

107

 Mean (SD)

46.7 (11.1)

50.6 (12.9)

52.1 (11.7)

Change from baseline

 n

105

105

 Mean (SD)

3.8 (9.8)

5.2 (8.1)

P value

<0.001

<0.001

WHO-5

 n

115

109

109

 Mean (SD)

5.6 (3.48)

10.8 (5.5)

12.8 (6.2)

Change from baseline

 n

108

109

 Mean (SD)

5.1 (5.4)

7.2 (6.6)

P value

<0.001

<0.001

  1. DSST Digit Symbol Substitution Test, PDQ-D Perceived Deficits Questionnaire-Depression, PHQ-9 Patient Health Questionnaire-Depressive Symptoms, SD standard deviation, WHO-5 World Health Organization-Five Well-Being Index